Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-26 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +57,500 57,500
2026-10-26 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +28,750 28,750
2026-10-19 Kulkarni Samarth Chief Executive Officer Sale −47,837 $49.78 $2.4M 311,899
2026-10-16 Kulkarni Samarth Chief Executive Officer Option exercise +100,000 359,736
2026-10-16 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −100,000 200,000
2026-10-14 Kulkarni Samarth Chief Executive Officer Sale −4,098 $49.26 $202K 259,736
2026-10-13 Kulkarni Samarth Chief Executive Officer Option exercise +8,333 263,834
2026-10-13 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −8,333 0
2026-03-23 Kulkarni Samarth Chief Executive Officer Sale −10,020 $46.78 $469K 255,501
2026-03-20 Kulkarni Samarth Chief Executive Officer Option exercise +19,687 265,521
2026-03-20 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +114,249 114,249
2026-03-20 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +81,875 81,875
2026-03-20 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −19,687 39,375
2026-03-16 Kulkarni Samarth Chief Executive Officer Sale −10,349 $48.26 $499K 245,834
2026-03-14 Kulkarni Samarth Chief Executive Officer Option exercise +20,625 256,183
2026-03-14 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −20,625 61,875
2026-03-11 Kulkarni Samarth Chief Executive Officer Sale −9,798 $52.80 $517K 235,558
2026-03-10 Kulkarni Samarth Chief Executive Officer Option exercise +19,250 245,356
2026-03-10 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −19,250 19,250
2026-02-19 Kulkarni Samarth Chief Executive Officer Sale −6,967 $52.58 $366K 226,106

Page 1 of 13 · 256 trades